This study demonstrated that NK cell-mediated tumour cell lysis is mediated by NKG2D- and DNAM-1-dependent pathways as treatment of NK cells with anti-NKG2D and anti-DNAM-1 antibodies significantly reduced the cytotoxic activity of NK cells [99]. The gene discussed is CD226; the disease is neoplasm.